The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 850.40
Bid: 852.80
Ask: 853.20
Change: 19.00 (2.29%)
Spread: 0.40 (0.047%)
Open: 857.60
High: 862.00
Low: 849.60
Prev. Close: 831.40
INF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Action Plan Update

11 Nov 2020 07:00

RNS Number : 9027E
Informa PLC
11 November 2020
 

 Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC Press Release

11 November 2020

COVID-19 Action Plan Update

Stability and Security

Informa (LSE: INF.L), the Information Services, Advanced Learning, B2B Exhibitions and Events Group is today providing a further update on its COVID-19 Action Plan, confirming the completion of its programme of financing activities, following the issue of a follow-on £150m Bond and the cancellation of its short-term Surplus Credit Facility and US Private Placement loan notes.

· Stability & Security in Financing: Informa's COVID-19 Financing Action Plan is now complete, providing the Group with long-term Stability and Security in relation to its balance sheet, with no debt maturities until 2023, no financial covenants and available liquidity of more than £1bn. This follows a series of financing activities over the last nine months in response to the COVID-19 pandemic, including:

· March: Securing access to a short-term £750m Surplus Credit Facility;

· April: Securing eligibility to access up to £300m via the Bank of England's COVID Corporate Financing Facility;

· April/May: Raising £1bn of new equity through a share placing;

· September: Issuing £640m equivalent Euro Bonds with 5-year maturities, a 2.125% coupon and no financial covenants;

· October: Issuing £150m follow-on Sterling Bonds to meet ongoing market demand, maturing in 2026 and with no financial covenants;

· November: The cancellation of our short-term £750m Surplus Credit Facility and £1.1bn US Private Placement loan notes, removing all financial covenants from Informa's balance sheet.

· Stability & Security in Cash Flow: The completion of our Financing Action Plan, combined with our ongoing Cost Management Programme, which is on track to deliver £600m of run-rate savings by the end of 2020, will ensure the Group is cash positive from January 2021, even assuming no physical events activity other than shows within Mainland China and outdoor events.

· 2020 Pre-Close Update: Given that Informa's Half-Year Results were published in late September, the Group intends to release a Pre-Close Trading Update (rather than a November Trading Update), following the end of the 2020 trading year.

Stephen Carter, Group Chief Executive, Informa PLC, said:

"Informa continues to build Stability and Security through 2021 and beyond, reflecting the combination of continuing strength in digital subscriptions, the progressive re-opening of physical events in Mainland China and other parts of Asia, and growth across our virtual events and media brands, alongside our ongoing cost and cash management programmes."

He added: "Following a nine-month programme of activity, we have now concluded the restructuring, refinancing and rescheduling of our debt. Combined with the continued delivery of our COVID-19 Action Plan, this ensures Informa is on track to deliver positive free cash flow from early 2021, with over £1 billion of available liquidity."

 

Enquiries

 

Stephen A. Carter, Group Chief Executive

+44 (0) 20 7017 5771

Gareth Wright, Group Finance Director

+44 (0) 20 7017 7096

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 3377 3445

Tim Burt / Zoe Watt - Teneo

+44 (0) 20 7240 2486

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPGUCGUPUGBU
Date   Source Headline
8th May 20247:00 amRNSMarket Update
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20249:18 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 202412:39 pmRNSAnnual Financial Report and Notice of 2024 AGM
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20244:45 pmRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20244:16 pmRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202410:00 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20249:59 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20244:12 pmRNSInforma 2023 Full Year Results Replacement
8th Mar 20247:00 amRNSInforma 2023 Full Year Results
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20249:00 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.